<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39318737</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0018-5787</ISSN><JournalIssue CitedMedium="Print"><Volume>59</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Hospital pharmacy</Title><ISOAbbreviation>Hosp Pharm</ISOAbbreviation></Journal><ArticleTitle>Chronic Immune Thrombocytopenia Purpura Following COVID-19 Vaccination (ChAdOx1 -nCov-19): A Case Report With OneYear Follow-Up.</ArticleTitle><Pagination><StartPage>552</StartPage><EndPage>556</EndPage><MedlinePgn>552-556</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/00185787241245914</ELocationID><Abstract><AbstractText><b>Background:</b> Immune Thrombocytopenia Purpura (ITP) is a hematological disorder, where its primary cause is unknown. This can be triggered through any secondary underlying diseases or other environmental agents such as drugs, vaccination, natural viral infections etc. After the introduction of COVID-19 vaccines, a 4-fold increase in ITP cases was observed globally. Many of the COVID-19 vaccines such as m-RNA and viral-vector vaccines already demonstrated a cause-effect relationship between the event of ITP and immunization. <b>Case presentation:</b> A 54 year old diabetic patient presented to the hospital with complaints of gum bleeding and fatigue. He was diagnosed with severe ITP following COVID-19 vaccination with a platelet count of 5000 cumm. Initially his condition was considered as idiopathic and the COVID-19 vaccine exposure (13 days prior to the clinical presentation) was not suspected. Later the immunization timeline and onset of the reaction was traced by his hematologist. The patient underwent multiple platelet transfusions and was given corticosteroid therapy. The patient was followed for a period of 1 year and throughout the follow-up period the patient had fluctuating platelets count, especially after tapering steroids. <b>Conclusion:</b> ITP in this case is found to have a consistent causal association to COVID-19 vaccination as per the World Health Organization Causality assessment algorithm and is categorized under vaccine product related reactions. One year follow-up conducted showed that the thrombocytopenia following COVID-19 vaccine may be prolonged.</AbstractText><CopyrightInformation>© The Author(s) 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Merrin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6354-2312</Identifier><AffiliationInfo><Affiliation>JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theempalangad</LastName><ForeName>Rovin M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sebastian</LastName><ForeName>Juny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Gulf Medical University, Ajman, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravi</LastName><ForeName>M D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hosp Pharm</MedlineTA><NlmUniqueID>0043175</NlmUniqueID><ISSNLinking>0018-5787</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">adverse drug reactions</Keyword><Keyword MajorTopicYN="N">adverse drug reactions reporting/monitoring</Keyword><Keyword MajorTopicYN="N">blood</Keyword><Keyword MajorTopicYN="N">long term care</Keyword><Keyword MajorTopicYN="N">medication safety</Keyword><Keyword MajorTopicYN="N">vaccines</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39318737</ArticleId><ArticleId IdType="pmc">PMC11418665</ArticleId><ArticleId IdType="doi">10.1177/00185787241245914</ArticleId><ArticleId IdType="pii">10.1177_00185787241245914</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Uptodate. Immune thrombocytopenia (ITP) in adults: clinical manifestations and diagnosis. Uptodate; 2023. Updated 2023. Accessed March 2, 2023. https://www.uptodate.com/contents/immune-thrombocytopenia-itp-in-adults-clinical-manifestations-and-diagnosis#H3</Citation></Reference><Reference><Citation>Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol. 2003;55(1):107-111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1884189</ArticleId><ArticleId IdType="pubmed">12534647</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller E, Waight P, Farrington CP, et al.. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child. 2001;84(3):227-229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1718684</ArticleId><ArticleId IdType="pubmed">11207170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh YL, Lin LH. Thrombocytopenic purpura following vaccination in early childhood: experience of a medical center in the past 2 decades. J Chin Med Assoc. 2010;73(12):634-637.</Citation><ArticleIdList><ArticleId IdType="pubmed">21145511</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Leary ST, Glanz JM, McClure DL, et al.. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics. 2012;129(2):248-255.</Citation><ArticleIdList><ArticleId IdType="pubmed">22232308</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan G, Liu H, Liang Z, et al.. Vaccine-associated thrombocytopenia. Thromb Res. 2022;220:12-20.</Citation><ArticleIdList><ArticleId IdType="pubmed">36265409</ArticleId></ArticleIdList></Reference><Reference><Citation>Moderna. MRNA-1272 sponsor briefing document. Vaccines and related biological products advisory committee meeting. FDA; 2020.</Citation></Reference><Reference><Citation>Pfizer-BioNTech. Pfizer-BioNTech COVID-19 vaccine briefing document. Vaccines and related biological products advisory committee meeting. FDA; 2020.</Citation></Reference><Reference><Citation>Ganzel C, Ben-Chetrit E. Immune thrombocytopenia following the Pfizer-biontech BNT162b2 mRNA COVID-19 vaccine. Isr Med Assoc J. 2021;23:341.</Citation><ArticleIdList><ArticleId IdType="pubmed">34155844</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EJ, Cines DB, Gernsheimer T, et al.. Thrombocytopenia following pfizer and moderna SARS-CoV-2 vaccination. Am J Hematol. 2021;96(5):534-537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014568</ArticleId><ArticleId IdType="pubmed">33606296</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon SF, Clothier HJ, Morgan H, et al.. Immune thrombocytopenia following immunisation with vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia. Vaccine. 2021;39(48):7052-7057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556135</ArticleId><ArticleId IdType="pubmed">34756770</ArticleId></ArticleIdList></Reference><Reference><Citation>Pai M, Chan B, Stall N, et al.. Vaccine-induced immune thrombotic thrombocytopenia (VITT) following adenovirus vector COVID-19 vaccination. Science Briefs. 2021;2(17):1-7.</Citation></Reference><Reference><Citation>Greinacher A, Thiele T, Warkentin TE, et al.. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. New Engl J Med. 2021;384(22):2092-2101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8095372</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>Noyé M, Lecompte T. Vaccination-induced thrombocytopenia and thrombosis (VITT) and pre-VITT: do not miss (or misdiagnose) the new member of the thrombotic thrombocytopenias family. Eur Heart J. 2022;2(5):oeac056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9491842</ArticleId><ArticleId IdType="pubmed">36156870</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo EJ, Wise RP, Menschik D, et al.. Thrombocytopenia after vaccination: case reports to the US vaccine adverse event reporting system, 1990–2008. Vaccine. 2011;29(6):1319-1323.</Citation><ArticleIdList><ArticleId IdType="pubmed">21126606</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the vaccine adverse event reporting system (VAERS). Vaccine. 2021;39(25):3329-3332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086806</ArticleId><ArticleId IdType="pubmed">34006408</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilotra M, Gupta M, Singh S, Sen R. Comparison of bone marrow aspiration cytology with bone marrow trephine biopsy histopathology: an observational study. J Lab Physicians. 2017;9(3):182-189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5496296</ArticleId><ArticleId IdType="pubmed">28706388</ArticleId></ArticleIdList></Reference><Reference><Citation>Montague SJ, Smith CW, Lodwick CS, et al.. Anti-platelet factor 4 immunoglobulin G levels in vaccine-induced immune thrombocytopenia and thrombosis: persistent positivity through 7 months. Res Pr Thromb Haemost. 2022;6(3):e12707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9066380</ArticleId><ArticleId IdType="pubmed">35515079</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulsen FO, Schaefers C, Langer F, et al.. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19). Blood. 2021;138(11):996-999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8313798</ArticleId><ArticleId IdType="pubmed">34297792</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Choi EJ, Park HS, et al.. A case report of immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. J Korean Med Sci. 2021;36(43):e306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575766</ArticleId><ArticleId IdType="pubmed">34751013</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano P, Cascioli S, Lassandro G, et al.. B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy. Pediatr Res. 2016;79(2):262-270.</Citation><ArticleIdList><ArticleId IdType="pubmed">26492283</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokomichi H, Tanaka-Taya K, Koshida R, et al.. Immune thrombocytopenic purpura risk by live, inactivated and simultaneous vaccinations among Japanese adults, children and infants: a matched case-control study. Int J Hematol. 2020;112(1):105-114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7223876</ArticleId><ArticleId IdType="pubmed">32253664</ArticleId></ArticleIdList></Reference><Reference><Citation>David P, Shoenfeld Y. ITP following vaccination. Int J Infect Dis. 2020;99:243-244.</Citation><ArticleIdList><ArticleId IdType="pubmed">32763445</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasin F, Calabrese A, Pelagatti L. Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality? Intern Emerg Med. 2022;17(1):295-297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8184050</ArticleId><ArticleId IdType="pubmed">34100214</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D, Portuguese AJ, Weatherford A, Garcia D, Gernsheimer T. Platelet trends after covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia. Am J Hematol. 2021;96(12):E472-E474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8616807</ArticleId><ArticleId IdType="pubmed">34619804</ArticleId></ArticleIdList></Reference><Reference><Citation>
Serum Institute of India. COVISHIELD – Fact sheet Eng-Hindi insert Ver.1.cdr. Accessed March 7, 2023. https://www.seruminstitute.com/pdf/covishield_fact_sheet.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>